Managed Access Program to Provide Access to Alpelisib for Patients With Advanced Breast Cancer
Status: AVAILABLE
Study type: EXPANDED_ACCESS
Conditions: HR+, HER2-, Advanced Breast Cancer
Interventions: DRUG: alpelisib
Sponsor: Novartis Pharmaceuticals